“Together with our colleagues in Cork, we’ll offer access to a fully integrated global network of world-class API facilities with deep experience, enabling us to be an even stronger partner for customers looking to outsource their API development and manufacturing,” said Patrick Glaser, president of Thermo Fisher’s drug substance business. “We look forward to helping our customers bring even more important new products to market and making a difference in patients’ lives.
